✦ LIBER ✦

Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report

✍ Scribed by Kim, Edward S; Putnam, Joe B; Komaki, Ritsuko; Walsh, Garrett L; Ro, Jae Y; Shin, Hyung Ju; Truong, Mylene; Moon, Hojin; Swisher, Steven G; Fossella, Frank V; Khuri, Fadlo R; Hong, Waun K; Shin, Dong M

Book ID: 119318866
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 329 KB
Volume: 44
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2003.12.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of induction high-dose ch

Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung

✍ Schilder, Russell J; Goldberg, Melvyn; Millenson, Michael M; Movsas, Benjamin; R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase II study of bi-weekly docetaxel an

Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer

✍ Sakai, H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Radiation Therapy Oncology Group Protoco

Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the Lung

✍ Mohan Suntharalingam; Rebecca Paulus; Martin J. Edelman; Mark Krasna; Whitney Bu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

O-040 Randomized phase III trial for sta

O-040 Randomized phase III trial for stage III unresectable nonsmall cell lung (NSCLC) cancer: Induction Chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)] followed by conventional radiation (RT) without (arm A) or with daily carboplatin (Cb) (arm B). Final results. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT

✍ Douillard, J.; Gervais, R.; Quoix, E.; Le Chevalier, T.; Le Groumellec, A.; Lema 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB